Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Myth-buster

Vitamin D supplementation showed a 45% lower odds of type 1 diabetes in a meta-analysis — but the result was not statistically significant and the confidence interval was wide.

This is among the first systematic reviews on this question, so the picture is genuinely uncertain — the nearly 50% lower odds could be real or could be chance, and larger studies are needed before drawing conclusions.

Analyzing existing studies together, vitamin D supplementation did not statistically significantly reduce the risk of developing type 1 diabetes (odds ratio 0.55, 95% CI 0.22–1.38) or islet autoimmunity (the early immune stage that can precede diabetes). The result is tantalizingly close to significance but remains inconclusive — it's not evidence that vitamin D works, nor evidence that it doesn't. The review notes the finding 'warrants further large-scale studies' and that vitamin D's effect was not significant.

Where this fits in the evidence

This is among the first studies we've indexed on Vitamin D for Developed Type 1 Diabetes — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top